KEGG   DISEASE: Factor V deficiency
Entry
H00220                      Disease                                
Name
Factor V deficiency;
Owren disease
Description
Factor V deficiency is an autosomal recessive hemorrhagic disorder, which is identified as an inherited resistance to the anticoagulant function of activated protein C.
Category
Hematologic disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 03 Diseases of the blood or blood-forming organs
  Coagulation defects, purpura or other haemorrhagic or related conditions
   Coagulation defects
    Congenital or constitutional haemorrhagic condition
     3B14  Other inherited coagulation factor deficiency with bleeding tendency
      H00220  Factor V deficiency
Pathway-based classification of diseases [BR:br08402]
 Immune system
  nt06514  Coagulation cascade
   H00220  Factor V deficiency
Pathway
hsa04610  Complement and coagulation cascades
Network
nt06514 Coagulation cascade
Gene
F5 [HSA:2153] [KO:K03902]
Other DBs
ICD-11: 3B14.Z
MeSH: D005166
OMIM: 227400
Reference
  Authors
Yamakage N, Ikejiri M, Okumura K, Takagi A, Murate T, Matushita T, Naoe T, Yamamoto K, Takamatsu J, Yamazaki T, Hamaguchi M, Kojima T
  Title
A case of coagulation factor V deficiency caused by compound heterozygous mutations in the factor V gene.
  Journal
Haemophilia 12:172-8 (2006)
DOI:10.1111/j.1365-2516.2006.01206.x
Reference
PMID:9576178
  Authors
Guasch JF, Cannegieter S, Reitsma PH, van't Veer-Korthof ET, Bertina RM
  Title
Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene.
  Journal
Br J Haematol 101:32-9 (1998)
DOI:10.1046/j.1365-2141.1998.00664.x
Reference
PMID:7590506
  Authors
De Stefano V, Leone G
  Title
Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
  Journal
Haematologica 80:344-56 (1995)
LinkDB

» Japanese version

KEGG   DISEASE: Inherited thrombophilia
Entry
H00223                      Disease                                
Name
Inherited thrombophilia;
Thrombophilia due to thrombin defect (THPH)
  Subgroup
Antithrombin III deficiency [DS:H01381]
Congenital dysfibrinogenemia [DS:H00222]
Description
Congenital thrombophilias are inherited disorders associated with an increased tendency to venous thromboembolism caused by mutation of genes affecting the anticoagulant pathways of blood coagulation.
Category
Hematologic disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 03 Diseases of the blood or blood-forming organs
  Coagulation defects, purpura or other haemorrhagic or related conditions
   3B61  Thrombophilia
    H00223  Inherited thrombophilia
Pathway-based classification of diseases [BR:br08402]
 Cellular process
  nt06535  Efferocytosis
   H00223  Inherited thrombophilia
 Immune system
  nt06514  Coagulation cascade
   H00223  Inherited thrombophilia
Pathway
hsa04610  Complement and coagulation cascades
hsa04611  Platelet activation
hsa04613  Neutrophil extracellular trap formation
hsa04148  Efferocytosis
Network
nt06514 Coagulation cascade
nt06535 Efferocytosis
Gene
(THPH1) F2 [HSA:2147] [KO:K01313]
(THPH2) F5 [HSA:2153] [KO:K03902]
(THPH3/4) PROC [HSA:5624] [KO:K01344]
(THPH5/6) PROS1 [HSA:5627] [KO:K03908]
(THPH7) SERPINC1 [HSA:462] [KO:K03911]
(THPH8) F9 [HSA:2158] [KO:K01321]
(THPH10) SERPIND1 [HSA:3053] [KO:K03912]
(THPH11) HRG [HSA:3273] [KO:K23410]
(THPH12) THBD [HSA:7056] [KO:K03907]
(THPH13) F8 [HSA:2157] [KO:K03899]
FGA [HSA:2243] [KO:K03903]
FGB [HSA:2244] [KO:K03904]
FGG [HSA:2266] [KO:K03905]
Other DBs
ICD-11: 3B61.0
MeSH: D019851
OMIM: 188050 188055 176860 612304 612336 300807 612356 613116 614486 301071
Reference
  Authors
Buchanan GS, Rodgers GM, Ware Branch D
  Title
The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation.
  Journal
Best Pract Res Clin Obstet Gynaecol 17:397-411 (2003)
DOI:10.1016/S1521-6934(03)00010-5
Reference
  Authors
Simioni P, Tormene D, Spiezia L, Tognin G, Rossetto V, Radu C, Prandoni P
  Title
Inherited thrombophilia and venous thromboembolism.
  Journal
Semin Thromb Hemost 32:700-8 (2006)
DOI:10.1055/s-2006-951298
Reference
  Authors
Dahlback B
  Title
Advances in understanding pathogenic mechanisms of thrombophilic disorders.
  Journal
Blood 112:19-27 (2008)
DOI:10.1182/blood-2008-01-077909
Reference
PMID:31577252 (THPH, FGA, FGB, FGG)
  Authors
Dautaj A, Krasi G, Bushati V, Precone V, Gheza M, Fioretti F, Sartori M, Costantini A, Benedetti S, Bertelli M
  Title
Hereditary thrombophilia.
  Journal
Acta Biomed 90:44-46 (2019)
DOI:10.23750/abm.v90i10-S.8758
Reference
PMID:22716977 (THPH1)
  Authors
Miyawaki Y, Suzuki A, Fujita J, Maki A, Okuyama E, Murata M, Takagi A, Murate T, Kunishima S, Sakai M, Okamoto K, Matsushita T, Naoe T, Saito H, Kojima T
  Title
Thrombosis from a prothrombin mutation conveying antithrombin resistance.
  Journal
N Engl J Med 366:2390-6 (2012)
DOI:10.1056/NEJMoa1201994
Reference
PMID:8164741 (THPH2)
  Authors
Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH
  Title
Mutation in blood coagulation factor V associated with resistance to activated protein C.
  Journal
Nature 369:64-7 (1994)
DOI:10.1038/369064a0
Reference
PMID:2437584 (THPH3)
  Authors
Romeo G, Hassan HJ, Staempfli S, Roncuzzi L, Cianetti L, Leonardi A, Vicente V, Mannucci PM, Bertina R, Peschle C, et al.
  Title
Hereditary thrombophilia: identification of nonsense and missense mutations in the protein C gene.
  Journal
Proc Natl Acad Sci U S A 84:2829-32 (1987)
DOI:10.1073/pnas.84.9.2829
Reference
PMID:10942114 (THPH4)
  Authors
Millar DS, Johansen B, Berntorp E, Minford A, Bolton-Maggs P, Wensley R, Kakkar V, Schulman S, Torres A, Bosch N, Cooper DN
  Title
Molecular genetic analysis of severe protein C deficiency.
  Journal
Hum Genet 106:646-53 (2000)
DOI:10.1007/s004390000315
Reference
PMID:7545463 (THPH5)
  Authors
Formstone CJ, Wacey AI, Berg LP, Rahman S, Bevan D, Rowley M, Voke J, Bernardi F, Legnani C, Simioni P, Girolami A, Tuddenham EG, Kakkar VV, Cooper DN
  Title
Detection and characterization of seven novel protein S (PROS) gene lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation  screening strategy.
  Journal
Blood 86:2632-41 (1995)
Reference
PMID:10063989 (THPH6)
  Authors
Pung-amritt P, Poort SR, Vos HL, Bertina RM, Mahasandana C, Tanphaichitr VS, Veerakul G, Kankirawatana S, Suvatte V
  Title
Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency.
  Journal
Thromb Haemost 81:189-92 (1999)
Reference
PMID:6582486 (THPH7)
  Authors
Koide T, Odani S, Takahashi K, Ono T, Sakuragawa N
  Title
Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
  Journal
Proc Natl Acad Sci U S A 81:289-93 (1984)
DOI:10.1073/pnas.81.2.289
Reference
PMID:19846852 (THPH8)
  Authors
Simioni P, Tormene D, Tognin G, Gavasso S, Bulato C, Iacobelli NP, Finn JD, Spiezia L, Radu C, Arruda VR
  Title
X-linked thrombophilia with a mutant factor IX (factor IX Padua).
  Journal
N Engl J Med 361:1671-5 (2009)
DOI:10.1056/NEJMoa0904377
Reference
PMID:2647747 (THPH10)
  Authors
Blinder MA, Andersson TR, Abildgaard U, Tollefsen DM
  Title
Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
  Journal
J Biol Chem 264:5128-33 (1989)
DOI:10.1016/S0021-9258(18)83708-5
Reference
PMID:9414276 (THPH11)
  Authors
Shigekiyo T, Yoshida H, Matsumoto K, Azuma H, Wakabayashi S, Saito S, Fujikawa K, Koide T
  Title
HRG Tokushima: molecular and cellular characterization of histidine-rich glycoprotein (HRG) deficiency.
  Journal
Blood 91:128-33 (1998)
DOI:10.1182/blood.V91.1.128
Reference
PMID:22036808 (THPH12)
  Authors
Anastasiou G, Gialeraki A, Merkouri E, Politou M, Travlou A
  Title
Thrombomodulin as a regulator of the anticoagulant pathway: implication in the development of thrombosis.
  Journal
Blood Coagul Fibrinolysis 23:1-10 (2012)
DOI:10.1097/MBC.0b013e32834cb271
Reference
PMID:33275657 (THPH13)
  Authors
Simioni P, Cagnin S, Sartorello F, Sales G, Pagani L, Bulato C, Gavasso S, Nuzzo F, Chemello F, Radu CM, Tormene D, Spiezia L, Hackeng TM, Campello E, Castoldi E
  Title
Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia.
  Journal
Blood 137:2383-2393 (2021)
DOI:10.1182/blood.2020008168
LinkDB

» Japanese version

KEGG   DISEASE: Budd-Chiari syndrome
Entry
H01433                      Disease                                
Name
Budd-Chiari syndrome
Description
Budd-Chiari syndrome (BDCHS) is a heterogeneous group of disorders characterized by hepatic venous outflow obstruction at the hepatic veins or inferior vena cava. Clinically, the disease is characterized by hepatomegaly, manifestations of portal hypertension, and sometimes rapidly deteriorating liver function. Factors that confer a predisposition to the development of the Budd-Chiari syndrome, including hypercoagulable states, both hereditary and acquired, and a variety of other causes, can be identified in about 75 percent of patients. The factor V Leiden mutation and V617F mutation in the JAK2 gene have been noted in patients with the Budd-Chiari syndrome.
Category
Digestive system disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 13 Diseases of the digestive system
  Diseases of liver
   DB98  Vascular disorders of the liver
    H01433  Budd-Chiari syndrome
Pathway-based classification of diseases [BR:br08402]
 Immune system
  nt06514  Coagulation cascade
   H01433  Budd-Chiari syndrome
Pathway
hsa04550  Signaling pathways regulating pluripotency of stem cells
hsa04659  Th17 cell differentiation
hsa04658  Th1 and Th2 cell differentiation
hsa04630  JAK-STAT signaling pathway
hsa04610  Complement and coagulation cascades
Network
nt06514 Coagulation cascade
Gene
F5 [HSA:2153] [KO:K03902]
JAK2 [HSA:3717] [KO:K04447]
Other DBs
ICD-11: DB98.5
MeSH: D006502
OMIM: 600880
Reference
  Authors
Menon KV, Shah V, Kamath PS
  Title
The Budd-Chiari syndrome.
  Journal
N Engl J Med 350:578-85 (2004)
DOI:10.1056/NEJMra020282
Reference
  Authors
Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, Gaken J, Wendon J, Heaton ND, Mufti GJ
  Title
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.
  Journal
Gastroenterology 130:2031-8 (2006)
DOI:10.1053/j.gastro.2006.04.008
Reference
  Authors
Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR
  Title
Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.
  Journal
Blood 96:2364-8 (2000)
Reference
  Authors
Mancuso A
  Title
Budd-Chiari syndrome management: Lights and shadows.
  Journal
World J Hepatol 3:262-4 (2011)
DOI:10.4254/wjh.v3.i10.262
LinkDB

» Japanese version

DBGET integrated database retrieval system